Matches in Nanopublications for { ?s ?p "[Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP1216051.RACdDcFK8pBxNC8OfFv7I9zomOQrJoIaOEEybQkGG5Oxg130_assertion description "[Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216051.RACdDcFK8pBxNC8OfFv7I9zomOQrJoIaOEEybQkGG5Oxg130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion description "[Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216050.RAEdiZddWqjlUj8EV4KR-GthQ9WL4z5ign8RCfE4Bb2YM130_assertion description "[Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216050.RAEdiZddWqjlUj8EV4KR-GthQ9WL4z5ign8RCfE4Bb2YM130_provenance.